Category Archives: Therapeutics

Surprise! Pharma says their “digital resources” are good for consumers

Sirensong Reliance on pharma-sponsored digital resources among online U.S. adults is significant. The research found “51% of online U.S. adults (ages 18+) use pharma-sponsored digital resources, such as condition and treatment information, disease management tools, doctor discussion guides, or mobile apps or websites.” This validates that the interactive information and tools produced by biopharma are… Read More »

Impact of Anti-infective Drug Shortages [Article]

Clinical Infectious Disease (online January 19): Abstract Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to… Read More »

The e-patient movement, panacea or barrier to care?

I haven’t really paid much attention to the e-patient movement, but recently it’s become a subject of interest. I Googled “epatient”, and here’s what I found: “e-Patients are health consumers who use the Internet to gather information about a medical condition of particular interest to them, and who use electronic communication tools in coping with… Read More »

Pharmacists impact on osteoporosis management (review article)

Pharmacists are pretty good at helping people with chronic medical conditions manage their medications, hence the term Medication Therapy Managment (MTM). You can find more information about MTM at the American Pharmacists Association (APhA) website. Anyway, I came across an article this morning that gives the results of a literature review “to examine the impact… Read More »

Bacteria everywhere run scared as vancomycin gets new life

medGadget: “Scientists from the Scripps Research Institute have successfully reengineered vancomycin. They have reported their findings in the Journal of the American Chemical Society. This research could be a solution in the treatment of patients infected with highly resistant bacteria. Vancomycin is often considered the antiobiotic of last resort, if other antibiotics have failed to… Read More »